Analysis of sputum in COPD

by MAESTRELLI, P, RICHELDI, L, MORETTI, M, FABBRI, L
Published 2001

Idiopathic pulmonary fibrosis in 2011: key updates on guidelines and therapeutics

by Costabel, U, Albera, C, Behr, J, Cottin, V, Guenther, A, Richeldi, L
Published 2013

Repeated tuberculin testing does not induce false positive ELISPOT results

by Richeldi, L, Ewer, K, Losi, M, Roversi, P, Fabbri, L M, Lalvani, A
Published 2006

Inactivation of polymerase inhibitors for Mycobacterium tuberculosis DNA amplification in sputum by using capture resin.

by Amicosante, M, Richeldi, L, Trenti, G, Paone, G, Campa, M, Bisetti, A, Saltini, C
Published 1995

Management of CAP using a validated risk score

by Richeldi, L, Guglielmo, M, Fabbri, L, Giovanardi, D, Marchetti, F, Larosa, M, Solfrini, V, Altini, M
Published 2005

Multidrug-resistant tuberculosis outbreak in an Italian prison: tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays

by Bedini, A., Garlassi, E., Stentarelli, C., Petrella, S., Meacci, M., Meccugni, B., Meschiari, M., Franceschini, E., Cerri, S., Brasacchio, A., Rumpianesi, F., Richeldi, L., Mussini, C.
Published in New Microbes New Infect (2016)

Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of Anti-infective Therapy (SITA) and the Italian S...

by Bassetti, M., Giacobbe, D.R., Aliberti, S., Barisione, E., Centanni, S., De Rosa, F.G., Di Marco, F., Gori, A., Granata, G., Mikulska, M., Petrosillo, N., Richeldi, L., Santus, P., Tascini, C., Vena, A., Viale, P., Blasi, F.
Published in Clin Microbiol Infect (2020)